Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Warts 4Condylomata Acuminata 2Virus Diseases 1Skin Diseases, Viral 1Skin Diseases, Infectious 1Skin Diseases 1Sexually Transmitted Diseases, Viral 1Sexually Transmitted Diseases 1Papillomavirus Infections 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 11Vaccines, Synthetic 7Papillomavirus Vaccines 6Vaccines 3Imiquimod 3Gels 3green tea extract polyphenone E 2Trichloroacetic Acid 2Duration of Therapy 2Cantharidin 2ranpirnase 1polyphenon E 1nanocurcumin 1human papillomavirus vaccine, L1 type 16, 18 1berdazimer sodium 1Viusid 1VP-102 1Therapies, Investigational 1Tea 1Surgical Procedures, Operative 1Omiganan 1Ointments 1Medical Records 1Interleukin-4 1Human Papillomavirus Recombinant Vaccine nonavalent 1Hepatitis B Vaccines 1GS-9191 1Ethanol 1Cyclophosphamide 1Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Condylomata Acuminata × Cantharidin × Clear all
NCT03981822 2024-11-27

CARE-1

Verrica Pharmaceuticals Inc.

Phase 2 Completed
105 enrolled 24 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Skin Diseases, Skin Diseases, Infectious, Virus Diseases, Warts, Sexually Transmitted Diseases, Viral, Skin Diseases, Viral, Papillomavirus Infections

NCT03625960 2018-08-10

Cantharone for the Treatment of Perenial Warts

Wayne State University

Phase 4 Completed
12 enrolled

Condylomata Acuminata, Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡